Fri, Jan. 23, 8:27 AM
- Kimberly-Clark (NYSE:KMB) reports organic sales growth of 3% in Q4.
- Segment revenue: Personal care: $2.34B (-1.3%); Consumer Tissue: $1.62B (-2.82%); K-C Professional: $857M (+1.3%).
- Segment operating profit: Personal care: $410M (+3.02%); Consumer Tissue: $280M (+1.82%); K-C Professional: $151M (+2.03%).
- FY2015 Guidance: Organic sales growth: 3% to 5%; Volume : +2% to +3%; Adjusted operating profit: +1% to +4%; Tax rate: 31.5% to 33.5%; Adjusted EPS: $5.60 to $5.80 (+2% to +5%); Capital expenditure: $950M to $1.05B.
- KMB -4.04% premarket.
Dec. 23, 2014, 9:35 AM| Comment!
Oct. 21, 2014, 9:18 AM
- Kimberly-Clark (NYSE:KMB) announces it will restructure itself in order to improve efficiency following the spinoff of its health care operation.
- The company's workforce will be reduced by 1,100 to 1,300 employees.
- Total costs for the restructuring are pegged at $130M-$160M.
- The action is expected to deliver pre-tax savings of $120M-$140M by the end of 2017.
- Previous: Q3 results, highlights.
- KMB +0.9% premarket.
Jul. 28, 2014, 3:31 PM
- A number of consumer goods companies that sell widely to retail chains are under-performing market indexes today after Dollar Tree announced it will buy out Family Dollar.
- Consolidation in the retail sector could give some leverage to the store chains as their scale broadens, according to Belus Capital Advisors' Brian Sozzi.
- On watch: PepsiCo (PEP -0.7%), Coca-Cola (KO -0.7%), Kraft Foods (KRFT -0.1%), Procter & Gamble (PG -0.4%), Colgate-Palmolive (CL -0.3%), Energizer Holdings (ENR -0.8%), Kimberly-Clark (KMB -0.3%).
- Related ETFs: XLP, VDC, FXG, IYK, RHS, FSTA, UGE, SZK
Jul. 14, 2014, 5:37 PM
Apr. 21, 2014, 9:14 AM| Comment!
Jan. 24, 2014, 7:42 AM
- Organic sales rose 5% during Q4 for Kimberly-Clark (KMB) as new product innovations contributed.
- The company saw volume gains of 4% and higher selling prices of 1% during the period.
- Sales in K-C International were up 5% despite a tough foreign exchange atmosphere, while lower selling prices in North America kept sales growth flat.
- KMB +1.1% premarket
Dec. 6, 2013, 10:03 AM
- Consumer staples stocks are getting some run out of a positive read on consumer sentiment and an improvement in the unemployment rate in the U.S. The group is outpacing broader market averages in early action.
- Advancers: Clorox (CLX) +2.2%, Procter & Gamble (PG) +2.0%, Energizer (ENR) +1.9%, Unilever (UL) +1.3%, Colgate-Palmolive (CL) +1.3%, Kimberly Clark (KMB) +1.1%, Avon Products (AVP) +1.0%.
- Related ETFs: XLP, VDC, FXG, RHS, PSL, PSCC, FSTA
Nov. 14, 2013, 4:29 PM
- A spin-off, says the company, would create a stand-alone, publicly traded firm with about $1.6B in annual sales. The unit's "strategic fit and growth priorities have changed over time and we now think that pursuing a spin-off makes sense for our shareholders," says CEO Thomas Falk.
- Robert E. Abernathy, currently Kimberly-Clark Group President Europe, Global Nonwovens, and Continuous Improvement and Sustainability, will be CEO of the new company.
- Management hopes to execute the spin-off by the end of 2014 Q3. It's expected to be in the form of a tax-free distribution of the new company's common stock to KMB shareholders.
- CC tomorrow at 10 ET.
- Press release
- KMB +4.3% AH.
Apr. 24, 2013, 10:48 AMThe rough patch hit by Procter & Gamble in emerging markets isn't giving unnoticed by some of its peers with Kimberly-Clark (KMB -1.2%), Colgate-Palmolive (CL -1.7%), and Clorox (CLX -1.5%) all showing weakness. ETF watch: Is the frothy run of consumer staple ETFs (XLP, FXG, VDC) at risk of running out of steam as sector rotation picks up? | 2 Comments
Apr. 19, 2013, 7:49 AMMore on Kimberly-Clark (KMB) Q1 earnings: FY2013 EPS guidance upped to $5.60-$5.75 vs. $5.50-$5.65 previously. Organic sales up 3% Y/Y, but revenue gain of just 1%, mostly thanks to currency moves. Operating profit gained 16% thanks to a 200 bp boost to margins. Completed $800M in share repurchases. Shares +3.6% premarket. (PR) | Comment!
Apr. 5, 2013, 7:45 AM
Apr. 2, 2013, 12:47 PMKimberly-Clark (KMB +1.7%) moves up after saying it's acquired the anesthesia business of Life-Tech, a Texas-based medical device manufacturer. The acquisition consists of needles, catheters and accessories associated with peripheral nerve block procedures, and the assets will become part of KMB's Health Care business and added to K-C Health Care's ON-Q family of products. | Comment!
Apr. 20, 2012, 12:17 PMKimberly-Clark's (KMB +2%) Q1 earnings and revenue beats push shares near 52-week highs. U.S. sales of Huggies diapers have been dropping, but CEO Tom Falk looks on the bright side, pointing to "reasons to believe the birth rate will turn from slightly negative to slightly positive later this year." KMB's strength also boosts PG +1.4%, CL +1.4%, which report earnings next week. | Comment!
Feb. 15, 2012, 2:44 PM
Jan. 24, 2012, 9:05 AM
KMB vs. ETF Alternatives
Other News & PR